[Latanoprost/netarsudil (primary open-angle glaucoma and ocular hypertension) – Addendum to Commission A22-129]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005104
Original Title: Latanoprost/Netarsudil (primäres Offenwinkelglaukom und okuläre Hypertension). Addendum zum Projekt A22-129 (Dossierbewertung)
Project Status: Completed
Year Published: 2023
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Latanoprost
  • Antihypertensive Agents
  • Intraocular Pressure
  • Prostaglandins F, Synthetic
  • beta-Alanine
  • Latanoprost
  • Netarsudil
  • Ocular Hypertension
  • Glaucoma – Open-Angle
  • Benefit Assessment
  • NCT03284853
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.